Il y a eu 50 transactions d'initiés récentes enregistrées pour RenovoRx, Inc. (RNXT), dont 47 achats et 1 vente. Le total des achats d'initiés s'élève à $2.11M et le total des ventes d'initiés à $3.07K.
Les initiés notables ayant une activité récente comprennent Voll Mark, Marton Laurence, Bagai Shaun. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.
Transactions d'Initiés — RNXT
| Date |
Nom |
Rôle |
Type de Transaction |
Actions |
Prix Moyen |
Valeur |
Actions détenues |
| 2026-03-25 |
Voll Mark |
Chief Financial Officer |
Attribution de RSU |
12,380 |
- |
- |
37,380 |
| 2026-03-20 |
Voll Mark |
Chief Financial Officer |
Achat Informatif |
48,600 |
$1.93 |
$93.92K |
48,600 |
| 2026-03-20 |
Marton Laurence |
Director |
Achat Informatif |
4,860 |
$1.93 |
$9.39K |
4,860 |
| 2026-03-20 |
Bagai Shaun |
Chief Executive Officer |
Achat Informatif |
12,150 |
$1.93 |
$23.48K |
12,150 |
| 2026-02-04 |
Voll Mark |
Chief Financial Officer |
Inconnu |
- |
- |
- |
25,000 |
| 2026-01-21 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
10,000 |
$1.00 |
$9.98K |
798,460 |
| 2025-12-31 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
9,795 |
$0.86 |
$8.42K |
788,460 |
| 2025-12-30 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
205 |
$0.83 |
$169.33 |
778,665 |
| 2025-12-18 |
Bagai Shaun |
Chief Executive Officer |
Achat Informatif |
5,000 |
$0.90 |
$4.51K |
340,040 |
| 2025-12-17 |
Bagai Shaun |
Chief Executive Officer |
Achat Informatif |
5,000 |
$0.85 |
$4.26K |
335,040 |
| 2025-12-16 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
12,000 |
$0.85 |
$10.2K |
778,460 |
| 2025-12-05 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
10,000 |
$0.96 |
$9.6K |
766,460 |
| 2025-11-24 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
12,000 |
$0.80 |
$9.6K |
756,460 |
| 2025-11-21 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
10,000 |
$0.80 |
$8K |
744,460 |
| 2025-10-01 |
Ryan Una S |
Director |
Attribution de RSU |
47,640 |
$1.34 |
$63.84K |
47,640 |
| 2025-10-01 |
Spiegel Robert J. |
Director |
Attribution de RSU |
47,640 |
$1.34 |
$63.84K |
47,640 |
| 2025-10-01 |
Macfarlane K. Angela |
Director |
Attribution de RSU |
47,640 |
$1.34 |
$63.84K |
47,640 |
| 2025-10-01 |
Marton Laurence |
Director |
Attribution de RSU |
47,640 |
$1.34 |
$63.84K |
47,640 |
| 2025-08-25 |
Bagai Shaun |
Chief Executive Officer |
Achat Informatif |
5,000 |
$0.91 |
$4.55K |
330,040 |
| 2025-08-22 |
Bagai Shaun |
Chief Executive Officer |
Achat Informatif |
5,000 |
$0.95 |
$4.75K |
325,040 |
| 2025-07-01 |
Bagai Shaun |
Chief Executive Officer |
Attribution de RSU |
102,498 |
$1.27 |
$130.17K |
102,498 |
| 2025-07-01 |
Agah Ramtin |
Chief Medical Officer |
Attribution de RSU |
63,636 |
$1.27 |
$80.82K |
63,636 |
| 2025-07-01 |
Kocak Ron |
VP, Controller and Pao |
Attribution de RSU |
41,600 |
$1.27 |
$52.83K |
41,600 |
| 2025-07-01 |
Gentry Leesa |
Chief Clinical Officer |
Attribution de RSU |
6,619 |
$1.27 |
$8.41K |
6,619 |
| 2025-06-05 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
21,000 |
$1.40 |
$29.4K |
734,460 |
| 2025-05-02 |
Marton Laurence |
Director |
Exercice d'Options (Vente) |
20,480 |
$0.15 |
$3.07K |
- |
| 2025-04-22 |
Agah Ramtin |
Chief Medical Officer |
Don (Donné) |
400,000 |
- |
- |
713,460 |
| 2025-04-15 |
Bagai Shaun |
Chief Executive Officer |
Achat Informatif |
7,500 |
$0.91 |
$6.82K |
320,040 |
| 2025-04-15 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
15,000 |
$0.90 |
$13.5K |
1,113,460 |
| 2025-04-14 |
Bagai Shaun |
Chief Executive Officer |
Attribution de RSU |
409,992 |
$0.84 |
$346.36K |
409,992 |
| 2025-04-14 |
Agah Ramtin |
Chief Medical Officer |
Attribution de RSU |
254,542 |
$0.84 |
$215.04K |
254,542 |
| 2025-04-14 |
Kocak Ron |
VP, Controller and Pao |
Attribution de RSU |
166,400 |
$0.84 |
$140.57K |
166,400 |
| 2025-04-14 |
Gentry Leesa |
Chief Clinical Officer |
Attribution de RSU |
26,477 |
$0.84 |
$22.37K |
26,477 |
| 2025-04-11 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
20,000 |
$0.80 |
$16K |
1,098,460 |
| 2025-04-10 |
Kocak Ron |
VP Controller and Pao |
Achat Informatif |
6,500 |
$0.79 |
$5.14K |
12,595 |
| 2025-04-09 |
Bagai Shaun |
Chief Executive Officer |
Achat Informatif |
10,000 |
$0.83 |
$8.3K |
312,540 |
| 2025-04-09 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
30,000 |
$0.81 |
$24.4K |
1,078,460 |
| 2025-04-09 |
Kocak Ron |
VP Controller and Pao |
Achat Informatif |
6,000 |
$0.80 |
$4.8K |
6,095 |
| 2025-04-08 |
Marton Laurence |
Director |
Achat Informatif |
12,050 |
$0.85 |
$10.22K |
45,684 |
| 2025-04-08 |
Agah Ramtin |
Chief Medical Officer |
Achat Informatif |
26,000 |
$0.84 |
$21.84K |
1,048,460 |
| 2025-04-08 |
Kocak Ron |
VP Controller and Pao |
Achat Informatif |
95 |
$0.80 |
$76.00 |
95 |
| 2025-04-07 |
Bagai Shaun |
Chief Executive Officer |
Achat Informatif |
10,000 |
$0.83 |
$8.3K |
302,540 |
| 2024-10-01 |
Ryan Una S |
Director |
Attribution de RSU |
25,099 |
$1.02 |
$25.6K |
25,099 |
| 2024-10-01 |
Spiegel Robert J. |
Director |
Attribution de RSU |
25,099 |
$1.02 |
$25.6K |
25,099 |
| 2024-10-01 |
Marton Laurence |
Director |
Attribution de RSU |
25,099 |
$1.02 |
$25.6K |
25,099 |
| 2024-10-01 |
Macfarlane K. Angela |
Director |
Attribution de RSU |
25,099 |
$1.02 |
$25.6K |
25,099 |
| 2024-03-06 |
Gentry Leesa |
Chief Clinical Officer |
Attribution de RSU |
190,000 |
$1.69 |
$321.1K |
190,000 |
| 2024-02-09 |
Kocak Ron |
VP, Controller and Pao |
Attribution de RSU |
15,000 |
$1.59 |
$23.85K |
15,000 |
| 2024-01-26 |
Spiegel Robert J. |
Director |
Achat Informatif |
40,983 |
$1.22 |
$50K |
40,983 |
| 2024-01-26 |
Marton Laurence |
Director |
Achat Informatif |
8,196 |
$1.22 |
$10K |
8,196 |
■ Informatif — transaction sur marché ouvert (la plus significative)
■ Non informatif (achat) — récompense, exercice d'option, conversion
■ Non informatif (vente) — retenue fiscale, vente à l'acquisition
■ Neutre — don, fiducie, expiration
Les autres consultent aussi
